Repeatability of SpotChecks contrast sensitivity test in macular disease
Optometry and Vision Science · 2026-07 · 103 (7)
DOI: 10.1002/ovs2.70082 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Optometry and Vision Science, online erschienen am 27.06.2026. Verfasst von Katlyn B Sprague und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Optometry, University of Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Contrast Sensitivity, Visual Acuity, Vision Tests, Macular Degeneration. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, National Eye Institute.
Abstract (Originalsprache)
Purpose
SpotChecks is an accessible contrast sensitivity test with good repeatability in healthy adults. This study compared its intra‐visit repeatability with the near Pelli–Robson test in adults with macular disease.
Methods
One eye from 29 adults with macular disease (mean age 71 ± 13 years) underwent high‐contrast logMAR acuity and two repeated contrast sensitivity measurements with SpotChecks and Pelli–Robson during one visit. All testing was performed at 40 cm using habitual correction under 110 cd/m 2 luminance. SpotChecks was scored as the contrast sensitivity at the highest row with two or more errors. Pelli‐Robson was scored as (0.05 × the number of correct letters −0.15). Repeatability was defined as 1.96 w ( S w , within‐subject standard deviation), and differences between tests and groups were compared using a bootstrap hypothesis test. Limits of agreement between SpotChecks and Pelli–Robson were assessed with Bland–Altman analysis. Results were compared with previously tested healthy adults.
Results
Mean visual acuity was 0.15 ± 0.13 logMAR. Mean contrast sensitivity (logCS) was 1.51 ± 0.18 for SpotChecks, 1.49 ± 0.18 for Pelli‐Robson. Repeatability was identical for SpotChecks and Pelli–Robson (0.17 logCS, p = 0.98) and comparable to normal values (SpotChecks: 0.19 logCS, p = 0.53; Pelli–Robson: 0.17 logCS, p = 0.87). Contrast sensitivity correlated with logMAR acuity (SpotChecks: r = −0.60; Pelli–Robson: r = −0.48; both p < 0.001). Limits of agreement between SpotChecks and Pelli–Robson were 0.03 ± 0.21 logCS. Abnormal contrast sensitivity (>2 SD below normal) was detected in 76% of eyes with SpotChecks and 66% with Pelli–Robson, exceeding 34% identified by logMAR acuity ( p < 0.001 and p < 0.02, respectively).
Conclusions
In adults with macular disease and good to mildly reduced visual acuity, SpotChecks demonstrated intra‐visit repeatability comparable to Pelli–Robson and healthy individuals. Receiver operating characteristic analysis showed comparable discriminative performance for SpotChecks and Pelli–Robson, both outperforming high‐contrast logMAR acuity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- College of Optometry, University of Houston, Houston, Texas, USA.
- Department of Mathematics, University of Houston, Houston, Texas, USA.
- Macula Vitreous Retina Physicians & Surgeons, Houston, Texas, USA.
- Baylor College of Medicine, Houston, Texas, USA.
- The George Washington University, Washington, District of Columbia, USA.
ORCID-Profile: Han Cheng
Förderung
- NEI NIH HHS
- National Eye Institute
Zitieren
APA
Sprague, K. B., Niu, Y., Carvounis, P. E., Patel, N. B., & Cheng, H. (2026). Repeatability of SpotChecks contrast sensitivity test in macular disease. Optometry and Vision Science, 103(7). https://doi.org/10.1002/ovs2.70082
Vancouver
Sprague KB, Niu Y, Carvounis PE, Patel NB, Cheng H. Repeatability of SpotChecks contrast sensitivity test in macular disease. Optometry and Vision Science. 2026;103(7). doi:10.1002/ovs2.70082
BibTeX
@article{Sprague2026,
author = {Sprague, Katlyn B and Niu, Yabo and Carvounis, Petros E and Patel, Nimesh B and Cheng, Han},
title = {Repeatability of SpotChecks contrast sensitivity test in macular disease},
journal = {Optometry and Vision Science},
year = {2026},
volume = {103},
number = {7},
doi = {10.1002/ovs2.70082}
}
EUVIMED